Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines

BACKGROUND: Methotrexate (MTX) is widely used as disease modifying treatment for psoriasis and psoriatic arthritis (PsA). Rheumatological and dermatological guidelines to prevent MTX-induced adverse events diverge in the number and frequency of blood tests. These differences are not based on evidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Busger op Vollenbroek, Felien T. M., Doggen, Carine J. M., Janssens, René W. A., Bernelot Moens, Hein J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865732/
https://www.ncbi.nlm.nih.gov/pubmed/29570708
http://dx.doi.org/10.1371/journal.pone.0194401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865732/
https://www.ncbi.nlm.nih.gov/pubmed/29570708
http://dx.doi.org/10.1371/journal.pone.0194401

Ejemplares similares